Lonza Group AG (LZAGY) Analyst/Investor Day October 14, 2026 12:00 PM EDT
Company Participants
Wolfgang Wienand – Chief Executive Officer
Philippe Deecke – Chief Financial Officer
Daniel Buchta – Head of Investor Relations
Gordon Bates – President of Small Molecules Division
Conference Call Participants
James Quigley – Goldman Sachs Group, Inc., Research Division
James Vane-Tempest – Jefferies LLC, Research Division
Zain Ebrahim – JPMorgan Chase & Co, Research Division
Charles Weston – RBC Capital Markets, Research Division
Thibault Boutherin – Morgan Stanley, Research Division
Falko Friedrichs – Deutsche Bank AG, Research Division
Charles Pitman – Barclays Bank PLC, Research Division
Odysseas Manesiotis – BNP Paribas, Research Division
Paul Knight – KeyBanc Capital Markets Inc., Research Division
Sebastian Bray – Joh. Berenberg, Gossler & Co. KG, Research Division
Justin Steven Smith – Bernstein Institutional Services LLC, Research Division
Patrick Rafaisz – UBS Investment Bank, Research Division
Charlie Haywood – BofA Securities, Research Division
Matthew Parisi – KeyBanc Capital Markets Inc., Research Division
Conversation
Wolfgang Wienand
Chief Executive Officer
Welcome to Vacaville, and a warm welcome to everyone here in the room who made the effort to actually come over to the other side of the world if you came over from Europe. But of course, also a warm welcome to anyone, all the ladies and gentlemen being with us today in the virtual webcast. We, as always, prepared a rich agenda for yourself, including me speaking about a great story at One Lonza and then handing over to Philippe, who will actually take you through the financial engine underlying and driving us forward. And then Gordon, as the Head of the Business Platform Biologics will take it down and provide further examples on how it looks like, specifically when it comes to biologics and drug product manufacturing.
Equally important, you will have at least those of you being with us here in Vacaville, you will have the opportunity
